Harrisvaccines was founded in 2005 by Dr. D.L. (Hank) Harris, one of the world's foremost authorities on infectious diseases of swine.
Harrisvaccines is developing vaccine technology for both the treatment and prevention of infectious diseases of swine. The advanced molecular approaches used by Harrisvaccines feature vaccines which differentiate infected from vaccinated animals (DIVA) using unique subunit proteins.
As an organization focused on improving the health and productivity of the swine industry, our objective is to provide cutting edge vaccines that are USDA licensed for diseases that increase the cost of producing pigs and are difficult to control with available technology.